Background: There has been growing interest in meditation techniques as an intervention in chronic disease populations. Little is known of the effect meditation practice has on outcomes among patients with heart failure. Purpose: To identify and examine current literature on meditation interventions on heart failure outcomes. Method: The review utilized methods described by Whittemore and Knafl. Three electronic databases were searched through March 2018. Terms used were "mindfulness OR meditation" and "heart failure" in combination, generating 58 articles after duplicates were removed. After inclusion and exclusion criteria were applied, six studies qualified for review, including four articles with samples from the United States and two with samples from Brazil and Sweden, respectively. Results: Among the six studies in the final sample, the total number of participants was 320 heart failure patients. Interventional design and length varied among the studies, and 20 different dependent variables were identified. This study distinguished four categories of outcome measures with significant findings: psychosocial, biophysical, quality of life and heart failure symptom burden. Compared with controls meditation practice significantly improved depression (p<.05), social support (p<.05), biophysical factors and quality of life (p<.05), in addition to reducing heart failure symptom burden. Across-study comparisons were limited due to variation in intervention definitions and designs. Additionally, the intervention dose and reporting method varied, limiting comparisons. The sample size in five out of six studies was fewer than 50 participants. Over 20 different measures were used across the six studies to measure outcome variables. Conclusion: Meditation may offer a patient-driven practice to reduce heart failure symptoms as well as improve psychosocial wellness and quality of life. Future research among heart failure patients should include the following: rigorous definition of meditation interventions, consistency in intervention characteristics, larger controlled trials, and standardized outcome instruments.
Introduction
Heart failure is a global epidemic affecting 26 million people. 1 The prevalence of heart failure is expected to increase in response to the growing incidence of risk factors, such as obesity and coronary artery disease. 1 Worldwide, heart failure related costs are currently estimated at US$108bn per year and predicted to increase. 2, 3 Most importantly, the syndrome of heart failure imposes significant burdens on patients due to symptoms which adversely affect morbidity, quality of life, and mortality. Interventional work focused on reducing the symptom burden for heart failure patients may improve their quality of life and reduce morbidity and costly hospitalizations. 4 There has been growing interest in meditation techniques as an intervention for symptom relief in chronic disease populations. 5 Under the umbrella of meditation, there are variations in practice depending on the thought or philosophy of the particular type of meditation. 5 While meditation can be defined in numerous ways, the definition operationalized in this review aligns with Walsh and Shapiro's, 6 which states that meditation "refers to a family of self-regulation practices that focus on training attention and awareness…" (p.229). Some researchers include tai chi and yoga as meditation practice; 7 however, for the purposes of this review, the authors limited the scope of the literature covered to meditation techniques without an exercise component. This allowed for seated meditation techniques, such as mindfulness and transcendental and compassionate meditation, to be incorporated in the review.
A large body of evidence demonstrates that meditation therapies are effective interventions for a range of psychological disorders, including anxiety and depression in participants with chronic illness, 8 although there is limited evidence in the heart failure literature. Meditation interventions have been associated with significant improvements in sleep quality among organ transplant patients 9 and exercise capacity in patients with chronic pulmonary obstructive disease, 10 as well as decreases in depressive symptoms in patients with multiple sclerosis. 11 Additionally, meditation practice has also improved quality of life measures among cancer patients. 12 Poor sleep quality, limited exercise capacity, depressive symptoms, and poor quality of life are also of concern for patients with heart failure.
The aim of this integrative review was to identify and examine the current literature for the characteristics of meditation interventions delivered, as well as the measures and outcomes in patients with heart failure. Three research questions guided the review: 
Methods

Study identification and selection
An integrative review of the literature was conducted utilizing methods described by Whittemore and Knafl. 13 The sampling decisions, including database and criteria for inclusion or exclusion, were mutually agreed upon by the authors prior to initiating the search. Three electronic databases-Cumulative Index to Nursing and Allied Health Literature, Medline, and PsychINFO-were searched through March 2018. The databases were selected because they include the majority of evidence regarding meditation interventions. The search terms "mindfulness OR meditation" and "heart failure" were used in combination. A rapidly growing area of high-quality research has been in the area of mindfulness-based meditation interventions, 9, 11, 12 which led to the inclusion of mindfulness as a search term. This search generated 58 articles after duplicates were removed ( Figure 1 ). In an effort to safeguard the rigor of the review, clear inclusion and exclusion criteria for article participation, in addition to measures for evaluating the quality of each study, were established by a consensus of all four authors in advance. Inclusion criteria for the integrative review were the following: (a) adult heart failure population (>18 years); (b) published in English; (c) identified as an empirical study, clinical trial, or randomized controlled trial; and (d) mindfulness or meditation as the intervention of study. Exclusion criteria included descriptive studies, abstracts, dissertations, and editorials. Additionally, trials that employed multicomponent interventions with exercise and meditation were excluded because the specific aspect of the intervention that contributed to any change could not be determined. This process most frequently resulted in the elimination of interventional designs using yoga or tai chi.
Data extraction and quality evaluation
Two reviewers independently read and abstracted data from each of the six articles that remained after the inclusion and exclusion criteria were applied. Data were added to an investigator-developed table that included design, sample, intervention, measures, outcomes, and quality ratings. Overall quality of the identified studies was evaluated utilizing guidelines from Hawker and colleagues, 14 including a critical appraisal tool and an evaluation protocol utilized to classify each study. The protocol defines each of nine measures in detail and scores each aspect as good (4), fair (3), poor (2), and very poor (1). The score for each measure was summed, generating a total score range of 9-36 for each article, with higher scores indicating better quality. Total scores for each article, converted to qualitative descriptions using previously published cut-points, were evaluated as follows: good scores ≥28; fair = 20-27; poor = 10-19; very poor ≤9. 15 To ensure inter-rater reliability, two authors appraised the quality of all articles meeting the inclusion criteria. Discrepancies were resolved through jointly comparing the publication with the criteria and engaging in discussion until consensus was reached.
Results
Search results
The integrative review revealed limited research on meditation as an intervention among heart failure patients. After accounting for inclusion and exclusion review criteria, a total of six studies qualified for review. The earliest identified study occurred in 2005, 16 and the most recent was published in 2018. 17 Four articles included samples from the United States, while the remaining two included samples from Brazil and Sweden, respectively. The sample size in five out of six studies was fewer than 50 participants. Moreover, 20 different measures were used across the six studies to measure outcome variables.
Research Question 1: What is the meditation intervention profile in terms of design and delivery among heart failure patients?
The total sample of heart failure patients across studies included 320 enrolled participants; across the studies, 14 initial enrollees did not complete the interventions, 169 participants completed the interventions and 137 enrollees were control subjects. The average age of participants within each study ranged from 56.9 years to 76 years, with varying standard deviations for each documented average age per study. The majority of participants in three of the studies were New York Heart Association (NYHA) classification II; additionally, one study utilized NYHA class II-III as an inclusion criterion. The study interventions varied in design. All of the studies provided face-to-face training sessions ranging from 1-h group-based training to 90 min in-home training. Five of the six studies required at least weekly meetings and meditation training. All six required self-reported practice of meditation activities to be completed at home, with each activity period varying in duration among 15 min (n=1), 20 min (n=3), and 30 min (n=2) and the daily frequency varying between once daily (n=4 studies) or twice daily (n=2 studies). The length of intervention differed among the studies to be eight weeks (n=3), three months (n=2), or six months (n=1). Additionally, there was diversity in the outcome measures. Among the six studies, 20 different dependent variables were identified, ranging from self-reported symptoms to biomarkers (Table 1) . [16] [17] [18] [19] [20] [21] The variation in outcome data limited viable comparisons across studies.
Interventionist. A unifying characteristic among five of the studies was the reported use of an interventionist trained in meditation. Although only one study addressed the training program, four referred to "experienced," "certified," or "qualified" practitioners. Reported interventionists were registered nurses (n=3 studies), a psychologist (n=2 studies), a physician (n=1 study), and counselors/instructors (n=2 studies). However, a description of the components of the training programs and standardized certification was not always present.
Dose. Each study required at least daily meditation practice. All studies articulated some sort of daily aid to support meditation, such as use of audio tapes/files or a patient manual on which to track progress. The length of exposure to meditation training varied among studies, ranging from eight weeks (n=3) to six months (n=1). Small cohorts were a design aspect in the two studies with larger enrollment, 18, 19 although it is not clear whether the small group decision was based on the ideal delivery of meditation training or was used due to recruitment and timing.
Content and delivery methods. Variation in content and delivery between studies was considerable. The clearest discrepancy identified involved content and outcomes of the meditation training. For instance, Heo and colleagues 17 examined the effect of an intervention that combined mindfulness and compassionate meditation with self-management techniques to reduce depressive symptoms and enhance perceived control. In contrast, Curiati and colleagues 16 focused on breathing and relaxation techniques with the aim of reducing sympathetic nervous system activation. An additional content disparity was related to the information delivered in tandem with mindfulness training; one study provided heart failure-specific education and provider visits in addition to traditional mindfulness training, 20 making it difficult to understand which aspect was most effective on outcome measures.
Research Question 2: What are the outcome measures in empirical investigations of meditation interventions among heart failure patients?
Four overall outcome categories were identified: psychosocial, biophysical, heart failure symptom burden, and quality of life (Table 1) . Psychosocial factors were considered in five out of the six studies. The most prevalent dependent variable, depression, was evaluated by three different instruments in four studies: the Center of Epidemiology-Depression Scale (n=2), the Patient Health Questionnaire-9 (n=1), or the PROMIS subscale for depression (n=1). Additional psychosocial factors evaluated were anxiety (n=2), perceived stress (n=2), perceived control (n=1), and perceived social support (n=1), with varying results.
Biological markers were measured in three studies. Researchers were interested in a range of serum biomarkers, such as norepinephrine 16 and brain natriuretic peptide. 21 Clinical indicators, such as the six-minute walk test or heart rate variation, were also explored as outcome variables. 18, 21 Cardiopulmonary exercise testing and echocardiography were evaluated in one study. 16 Heart failure symptoms were outcome measures in four investigations. Various instruments were used to measure sleep, fatigue, activity tolerance, and perceived symptom burden. Each of the four investigations utilized different instruments to evaluate symptom burden. Furthermore, quality of life or satisfaction with life was evaluated in the majority of studies (n=4). Most often the instrument utilized was the Minnesota Living with Heart Failure Questionnaire (MLHFQ) (n=3). Kemper and colleagues employed the Satisfaction with Life Scale. 20 
Research Question 3: What are the effects of meditation interventions on heart failure patients?
Positive effects on psychosocial dependent variables were recognized ( Table 2 ). Three of the four studies that measured depression identified significant improvement (p<.05) among heart failure participants with the use of meditation. 17, 19, 21 The effects of meditation interventions on biophysical findings were inconsistent. The distance walk for 6 min was significantly improved (p=.034) in the study conducted by Jayadevappa and colleagues, 21 while not improved in Norman and colleagues' 18 investigation (p=.112) after meditation intervention. Additionally, norepinephrine was reduced in the intervention group (p=.009) in the Curiati et al. study, 16 but oxygen consumption (VO 2 mL/kg per min), left ventricular ejection fraction, or left ventricular diastolic diameter index did not significantly change.
Some variation of heart failure symptom improvement was identified in three studies, as follows: Sullivan and colleagues 19 used the Kansas City Cardiomyopathy Questionnaire symptom scale, which had improved scores on its total symptom score (p<.05) and clinical summary score (p<.05). The Symptom Status Questionnaire-Heart Failure was employed by Heo and colleagues 17 and demonstrated that heart failure symptoms at follow-up compared with at baseline were significantly reduced (p=.003). Norman and colleagues 18 reported an improvement in fatigue severity (p=.017). Also, quality of life was improved in three out of four studies. The findings from two studies show significant improvements in the MLHFQ results (p=.02; 16 p=.003 17 ). Kemper and colleagues reported improvements on the Satisfaction with Life Scale post-intervention; however, no control was utilized for comparison. 20
Discussion
Overall, this review identifies meditation as a useful intervention to improve quality of life, psychosocial and biophysical factors, and reduce heart failure symptom burden for patients with heart failure. The findings described in this review support the evidence presented in the literature among participants with other chronic illnesses. 5, 22 Consistent with prior research in areas of cancer 23 and fibromyalgia, 24 meditation practice significantly improved depression (p<.05) and quality of life (p<.05).
In general, the meditation intervention characteristics varied from study to study. There was disparity in content and the length of participation and interventionists differed in their roles and qualifications. Clear communication of the dose, content, and interventionist qualifications are needed to inform future studies. An additional area of awareness is related to the heavy reliance on patients' selfreport as a measure of the interventional dose. Development of reliable tracking processes to measure the actual dose of intervention delivered is important. Beyond that, communicating the mechanisms that support the relationship between the intervention and dependent variables is necessary. These issues occurred across most studies and limit the generalizability of the findings. However, the findings of this review indicate that meditation may have positive effects among psychosocial, biophysical, heart failure symptom burden, and quality of life.
Four studies evaluated depression as a psychosocial outcome variable (n=2 with controls), with three demonstrating significant improvement. It may be difficult, however, to identify whether the depression symptoms were impacted by the group meetings and socialization involved in the training, or whether the intervention did so independently since participants received more than usual care. Larger studies with attention control groups and varying dose or treatment response groups would help address this concern. Larger samples allow greater statistical control and precision in determining the unique effect of each of these variables on the outcome measures. The biophysical response to meditation is identified as an area for further exploration. Meditation participants demonstrated a change in the marker often used to represent ventilatory efficiency (the rate of increase of ventilation per unit of increase of carbon dioxide production (VE/ VCO 2 slope). 16 The role that breathing exercises during meditation may have on ventilatory strength, oxygenation processes, and ultimately perfusion is an interesting area for further investigation.
Patients reported decreased shortness of breath in the meditation intervention groups when compared with controls as an aspect of their heart failure symptoms. 18 Symptom burden is a problematic issue for heart failure patients. 25 Perhaps the meditation practice may lead to an increased recognition of mild breathlessness. Further research to understand these mechanisms is warranted.
One of the major effects of meditation in the studies reviewed was improvements in quality of life, which was measured in four of the six studies, with only one study demonstrating no improvement. These findings were consistent with those in prior studies with various chronic disease populations. 26, 27 Quality of life is an established priority for patients with heart failure. 28 However, there is limited data (n=4 studies) to support meditation as an intervention to improve quality of life in the heart failure population. Further research in this area is warranted.
Limitations
The small number of studies confines the generalizability of this review. The heterogeneity of intervention design limits the understanding of how the content or length of time in meditation practice contributes to the outcomes. Additionally, the variability in outcome measures may contribute to differential results.
Conclusions
This review provides a summary of the evidence on meditation as an intervention for heart failure patients. The findings of this review show that meditation interventions improve quality of life and biophysical and psychosocial factors and reduce heart failure symptom burden. While this is an emerging area of investigation, several important opportunities to improve future research were identified. Researchers should consider the following: (a) more rigorous methodology to define meditation, standardizing the characteristics of the intervention and qualifications of the interventionists; (b) conducting more large-scale controlled trials of meditation interventions with adequate placebo controls; and (c) systematizing outcome measures to increase the generalizability of findings and advance the quality of evidence regarding meditation interventions in the heart failure population. Clinically, meditation may offer a patient-driven practice to reduce heart failure symptoms as well as improve psychosocial wellness and quality of life.
Implications for practice
• • Meditation is an emerging area of investigation in the heart failure population. • • Meditation practice may provide biophysical and heart failure symptom burden benefits. • • Evidence supports the use of meditation to improve psychosocial wellness and quality of life.
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